Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-09-25
1998-08-25
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3120
Patent
active
057983895
ABSTRACT:
A medicine effective in inhibiting glomerulonephritis is developed. A glomerulonephritis inhibitor contains, as an effective ingredient thereof, docosahexaenoic acid or a salt, ester, or amide thereof or other docosahexaenoic acid derivative.
REFERENCES:
patent: 5434183 (1995-07-01), Larsson-Backstrom
CA 115:235179, Latyshev et al., 1991.
CA 109:128397, Yamaguchi et al., 1988.
Dwight R. Robinson et al., J. Lipid. Res., vol. 34, no. 8, 1993.
Raffaele De Caterina et al., Kidney Int., vol. 44, No. 4, 1993.
Ralph T. Holman et al., Am. J. Kidney Dis., vol. 23, No. 5, 1994.
Charles Van Ypersele de Strihou, New Engl., J. Med., vol. 23, No. 5, 1994.
Kanayama Toshiji
Uchiyama Taro
Yanagisawa Isao
Jordan Kimberly
Shiseido Co. Ltd.
Snider Ronald R.
LandOfFree
Glomerulonephritis inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glomerulonephritis inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glomerulonephritis inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36735